Vanguard Group
LPTX icon

Vanguard Group’s Leap Therapeutics LPTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$345K Sell
1,160,680
-14,918
-1% -$4.43K ﹤0.01% 3997
2025
Q1
$359K Sell
1,175,598
-15,385
-1% -$4.69K ﹤0.01% 3958
2024
Q4
$3.42M Buy
1,190,983
+161,830
+16% +$465K ﹤0.01% 3402
2024
Q3
$2.64M Buy
1,029,153
+32,918
+3% +$84.6K ﹤0.01% 3473
2024
Q2
$1.95M Buy
996,235
+128,527
+15% +$252K ﹤0.01% 3559
2024
Q1
$2.31M Buy
867,708
+457,904
+112% +$1.22M ﹤0.01% 3546
2023
Q4
$1.7M Buy
409,804
+75,091
+22% +$311K ﹤0.01% 3658
2023
Q3
$462K Buy
334,713
+7,775
+2% +$10.7K ﹤0.01% 4071
2023
Q2
$1.02M Sell
326,938
-2,883,864
-90% -$9.03M ﹤0.01% 3893
2023
Q1
$1.09M Hold
3,210,802
﹤0.01% 3886
2022
Q4
$1.44M Sell
3,210,802
-53,369
-2% -$24K ﹤0.01% 3786
2022
Q3
$2.87M Buy
3,264,171
+7,840
+0.2% +$6.9K ﹤0.01% 3601
2022
Q2
$3.74M Hold
3,256,331
﹤0.01% 3525
2022
Q1
$5.7M Buy
3,256,331
+137,159
+4% +$240K ﹤0.01% 3466
2021
Q4
$10.1M Buy
3,119,172
+416,547
+15% +$1.35M ﹤0.01% 3193
2021
Q3
$10.8M Buy
2,702,625
+600,128
+29% +$2.41M ﹤0.01% 3196
2021
Q2
$3.45M Sell
2,102,497
-413
-0% -$677 ﹤0.01% 3773
2021
Q1
$4M Buy
2,102,910
+203,730
+11% +$387K ﹤0.01% 3642
2020
Q4
$4.27M Buy
1,899,180
+371,125
+24% +$835K ﹤0.01% 3430
2020
Q3
$3.03M Buy
1,528,055
+50,100
+3% +$99.2K ﹤0.01% 3365
2020
Q2
$3.09M Buy
1,477,955
+805,440
+120% +$1.68M ﹤0.01% 3304
2020
Q1
$1.06M Hold
672,515
﹤0.01% 3470
2019
Q4
$753K Hold
672,515
﹤0.01% 3698
2019
Q3
$787K Buy
672,515
+117,320
+21% +$137K ﹤0.01% 3711
2019
Q2
$994K Buy
555,195
+359,320
+183% +$643K ﹤0.01% 3680
2019
Q1
$366K Buy
195,875
+57,668
+42% +$108K ﹤0.01% 3825
2018
Q4
$276K Sell
138,207
-118,061
-46% -$236K ﹤0.01% 3838
2018
Q3
$2M Buy
256,268
+48,300
+23% +$376K ﹤0.01% 3527
2018
Q2
$1.87M Buy
207,968
+118,677
+133% +$1.07M ﹤0.01% 3518
2018
Q1
$741K Buy
89,291
+50,985
+133% +$423K ﹤0.01% 3720
2017
Q4
$239K Buy
38,306
+1,600
+4% +$9.98K ﹤0.01% 3898
2017
Q3
$213K Buy
+36,706
New +$213K ﹤0.01% 3903